Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
764.00    -4.00 (-0.52%)
Bid:
763.00
Ask:
764.50
Spread: 1.50 (0.197%)
Market Cap: £1.54b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Director/PDMR Shareholding

31 Oct 2025 09:52

RNS Number : 7036F
Dunelm Group plc
31 October 2025
Β 

31 October 2025

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS EXERCISING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

On 30 October 2025 share incentive awards were granted over ordinary shares of one pence each in the Company, in the form of a nil cost option under the Dunelm Group 2014 Long Term Incentive Plan to the following persons discharging managerial responsibilities:

PDMR

Number of shares under award

Clo Moriarty

146,981

Karen Witts

86,390

Luisa Wright

24,618

James Cooper

3,677

Β 

In the case of Clo Moriarty, Karen Witts and Luisa Wright, the options may be exercised on or after 30 October 2028, subject to the satisfaction of performance conditions over the three financial periods commencing on 29 June 2025. These performance conditions are detailed in the Company's FY25 Annual Report. In the case of James Cooper, the options may be exercised on or after 30 October 2027, subject to the satisfaction of performance conditions.

On exercise, Clo Moriarty and Karen Witts have each committed to retain (after sale to cover tax and national insurance liability on exercise), at least two thirds of these for the duration of employment. In addition, shareholding requirements apply for the duration of employment and for two years from termination of employment, as set out in the 2023 Remuneration Policy ("2023 Policy") approved on 16 November 2023.

In line with its 2023 Policy, the Remuneration Committee can apply malus or clawback to the awards and has discretion to vary formulaic outturns where this does not reflect underlying performance or is inappropriate in the context of unexpected or unforeseen circumstances.

Β 

For further information please contact:Β 

Β 

Dunelm Group plc

Luisa Wright/Simon Hockridge

Β 

Β 

InvestorRelations@dunelm.com

Β 

Β 

MHP Communications

Β 

Β 

Rachel Farrington/Charles Hirst

Β 

Β 

dunelm@mhpc.com

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Β 

1

Β 

Details of the person(s) discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

1. Clodagh Moriarty

2. Karen Witts

3. Luisa Wright

4. James Cooper

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

1. Chief Executive

2. Chief Financial Officer

3. PDMR

4. PDMR

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Dunelm Group plc

b)

Β 

LEI

Β 

213800WCOWEI3T5DUV19

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of one pence eachΒ 

Β 

Β 

ISINGB00BICQ739

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost share options conditional on future performance in accordance with the Company's long term incentive plan

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

1. Β£Nil

2. Β£Nil

3. Β£Nil

4. Β£Nil

Β 

146,981

86,390

24,618

3,677

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

Β Single transaction for each individual

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

2025.10.30

f)

Β 

Place of the transaction

Β 

Β 

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPKDBQCBDKFKN
Date   Source Headline
7th Sep 20227:00 amRNSConfirmation of Board Change
6th Sep 20221:20 pmRNSDirector Declaration
31st Aug 20224:05 pmRNSHolding(s) in Company
31st Aug 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSHolding(s) in Company
8th Aug 20221:59 pmRNSDirector/PDMR Shareholding
8th Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSTotal Voting Rights
21st Jul 20227:02 amRNSAppointment of Independent NED and Chair Designate
21st Jul 20227:02 amRNSFull year trading update
30th Jun 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSTransaction in Own Shares
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 20227:00 amRNSTransaction in Own Shares
13th Jun 20227:00 amRNSDirector/PDMR Shareholding
13th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSDirector/PDMR Shareholding
9th Jun 20227:00 amRNSConfirmation of Board Changes
9th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20227:00 amRNSTransaction in Own Shares
7th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 20227:00 amRNSTotal Voting Rights
12th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSDirector/PDMR Shareholding
29th Apr 20227:00 amRNSTotal Voting Rights
20th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 202210:30 amRNSBlock Listing Six Monthly Return
14th Apr 202210:30 amRNSBlock Listing Six Monthly Return
14th Apr 202210:30 amRNSBlock Listing Six Monthly Return
14th Apr 202210:30 amRNSBlock Listing Six Monthly Return
14th Apr 202210:30 amRNSBlock Listing Six Monthly Return
14th Apr 20227:00 amRNSThird quarter trading update
1st Apr 20227:00 amRNSAppointment of Chief Financial Officer
31st Mar 20227:00 amRNSTotal Voting Rights
15th Mar 20227:00 amRNSTransaction in Own Shares
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 20227:00 amRNSTransaction in Own Shares
7th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20227:00 amRNSTransaction in Own Shares
1st Mar 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.